These drugmakers may not be in perfect health right now, but that shouldn't last much longer.Few pharmaceutical companies are more prominent than Pfizer (PFE 0.91%) and Bristol Myers Squibb (BMY -0.71%). However, their popularity relative to most of their peers hasn't helped them much in the past few years: Both drugmakers have substantially lagged the market. Pfizer and Bristol Myers have had their share of troubles, but there is plenty to like about both stocks, at least for investors with an investment h ...